Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Fertil Steril. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as:
PMCID: PMC2692532

Association between blocking folate receptor autoantibodies and subfertility


The association between blocking folate receptor (FR) autoantibodies and subfertility was investigated in a longitudinal study of women attempting to become pregnant. 17 women with subfertility (failure to conceive during 12 menstrual cycles) and 25 control women (conceived and went on to have normal pregnancy outcomes) were studied. Subfertility risk was 12 times higher in women with blocking FR autoantibodies compared to those without (OR= 12 [95% CI]: 1.9 to 129.6, p<0.05).

Keywords: Folate receptor autoantibodies, subfertility, pregnancy

Folate plays an important role in human reproduction (1, 2). It is essential for genomic integrity and DNA methylation (3). Insufficient folate supply during the rapid cell division phase following conception has been associated with neural tube defects (NTDs) (4, 5, 6), impaired embryo viability and implantation (7), increased rate of apoptosis in human cytotrophoblastic cells (8) and risk of spontaneous abortion (9). Immunohistochemical evidence of folate receptor (FR) expression in different reproductive tissues of both pregnant and non-pregnant female rats and in different anatomical components of the embryo at different stages of development has been reported and a specific antiserum capable of blocking the binding of folate to its receptor, before conception, proposed as a cause of infertility (10). Maternal FR autoantibodies capable of blocking folate transport have been reported to be more frequent in women with NTD-affected pregnancies than in controls (11,12). Blocking FR autoantibodies in children have been associated with cerebral folate deficiency (13, 14), autism (15) and Rett Syndrome (16).

Approximately 25% of pregnancies are clinically undetected due to early pregnancy loss (17) and 12% end in spontaneous abortion (18). Subfertility [lower than normal probability of conception during a given menstrual cycle (19)] is another complication associated with the very early stages of conception and human development. The timing and difficulty in detecting these events complicates the investigation of their etiology, especially in the case of first time occurrence.

Blockage of FR by maternal FR autoantibodies during the periconception period could alter folate bioavailability during the primary stages of cellular division and embryogenesis. This could lead to subfertility/early pregnancy loss. The aim of this study was to investigate the association between maternal blocking FR autoantibodies and subfertility.

Women planning pregnancy participated in the PREC (PRE Conception) longitudinal study of maternal nutritional status from preconception throughout pregnancy (Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili and Unit of Obstetrics and Gynecology, University Hospital Sant Joan, Reus [1991–1996]) (2123). Ethics committee approval was obtained and signed informed consent provided from the participants in accordance with the Declaration of Helsinki (20). Exclusion criteria were previous diagnosis of infertility or chronic illnesses affecting nutritional status and use of medication interfering with folate metabolism. Data regarding lifestyle, toxic habits, vitamin/mineral supplement and recent oral contraceptive use was collected and BMI (body mass index) was recorded.

The collection of a fasting blood sample between days 7 to 12 of the menstrual cycle was scheduled on the first day of that cycle. Samples from the antecubetal vein were collected into EDTA-K3 treated vacutainers, kept at 4°C and processed within 2 hours of collection. Plasma was stored in aliquots at −20°C. If the participant had not become pregnant during 3 cycles, another blood sample was collected. Subfertility cases were participants who after providing 3 preconception blood samples had not become pregnant and who confirmed not being pregnant when contacted to schedule a fourth preconception sample (after 12 menstrual cycles of trying). 17 cases of subfertility were detected. Controls were 25 participants that became pregnant after providing a preconception blood sample and provided further blood samples at weeks 8, 20 and 32 gestation and at labor and from the umbilical cord from normal term pregnancies.

None of the participants took folic acid supplements during the periconception phase of the study. It was carried out before the current recommendation for periconceptional folic acid supplementation was in place in Spain. Flour in Spain is not fortified with folic acid.

Testing for blocking autoantibodies against FR was performed at SUNY Downstate Medical Center as previously described (11, 13). Briefly, 200 μl of serum was acidified with 300 μl of 0.1 molar glycine/HCl, pH 2.5/0.5% Triton X-100/10 mM EDTA and was added to 12.5mg of dextran-coated charcoal pellets to remove free folate. Following centrifugation, the supernatant was collected and the pH raised to 7.4 with 62 μl of 1 M dibasic sodium phosphate. This sample was incubated overnight at 4°C with 0.34 pmols of apo-FR purified from bovine milk. Tritiated ([3H]) folic acid was added and the mixture incubated for 20 minutes at room temperature. Free [3H]folic acid was adsorbed to dextran coated charcoal and receptor-bound radioactivity in the supernatant fraction determined. Blocking autoantibodies prevent the binding of [3H]folic acid to FR and the autoantibody titer is expressed as pmol FR blocked/ml of plasma. Total fasting plasma homocysteine (tHcy) was determined by the IMx immunoassay (Abbott Laboratories, Diagnostics Division, Abbott Park IL). Statistical analysis was performed using SPSS (Ver. 15.0) software. Frequency of blocking FR autoantibody occurrence and smoking habits and use of oral contraceptives (dichotomic variables) between cases and controls was compared using the Chi-square test and mean age and BMI compared using ANOVA. The Odds Ratio (OR) of having subfertility when positive for blocking FR autoantibodies compared with not having them was estimated by logistic regression analysis adjusting for age, smoking habit, BMI and tHcy. The significance level was set at p<0.05.

The baseline characteristics summarized in Table 1 did not differ significantly between cases and controls. A total of 83 repeated blood samples collected 10–12 weeks apart were available for cases and 104 for controls. 18/83 samples collected from cases had positive FR autoantibody titers compared to 1/104 samples collected from controls (p<0.001). At least one positive reading for FR autoantibodies was observed in 29.4% (5/17) [Mean (SD) titer: 0.88 (0.39) pmols FR blocked/ml plasma] of the subfertility cases compared to in 4% (1/25) [titer: 0.19 pmols FR blocked/ml plasma] of the control group (p<0.05). Autoantibody titers fluctuated to different degrees in the 6 women who had tested positive in repeated blood samples 12 weeks apart: 2/7 readings over 23 months, 1/10 readings over 31 months, 3/4 readings over 14 months, 5/6 readings over 15 months, 2/3 readings over 12 months and 1/2 readings over 3 months were below the assay’s detection limit (0.1 pmol FR blocked/ml). The remaining 36 women had negative readings for antibodies on all occasions (up to 7 times, each 10–12 weeks apart). The risk of subfertility was 12 times higher in women with autoantibodies compared to those without (OR=12 [95% CI]: 1.9 to 129.6, p<0.05). 5/17 cases went on to become pregnant after between 12–19 months of trying. Only 1 case positive for blocking FR autoantibodies became pregnant after 19 months. She went on to have a term pregnancy with the baby’s birth weight between P25-P50.

Baseline (preconception) characteristics of cases and controls for subfertility.

Approximately 30% of cases of subfertility reported in previous studies were not explained by conventional causes (25, 26). In our sample of Spanish women of fertile age, we observed that having autoantibodies that block folate transport at the FR level is a significant risk factor for subfertility. Folate cell delivery via the folate receptor is especially important in reproductive processes (26). Impairment of this mechanism could affect DNA synthesis and repair, apoptosis and trigger oxidative stress mechanisms. This could lead to impaired gamete quality, implantation, fetus development and pregnancy maintenance as reported in folate deficiency (27, 28).

DNA hypomethylation has also been reported to affect the expression of Cyp19, the key gene of estrogen biosynthesis (29).

The importance of FR in cellular folate uptake and the difficulty in successfully conceiving when FR function is inhibited, were previously reported in rats (10). Maternal blocking FR autoantibodies have been associated with developmental problems in the embryo during the very early stages of pregnancy (11). Reduced folate is essential in preimplantation embryos (7). Conceivably in the case of subfertility, insufficient reduced folate during the rapid cell division phase following conception, may prevent embryo viability and implantation or pregnancy maintenance (7, 10). We investigated the presence of blocking FR autoantibodies in repeated samples collected longitudinally, and at relatively close time intervals. We detected blocking FR autoantibodies both before and during pregnancy and observed that in some cases titers fluctuated to levels below the detection limit. Such fluctuations in antibody titer especially when the titer is low, have been observed in other autoimmune conditions (30, 31). Questions as to what triggers FR antibody response and what factors contribute to fluctuations in the titer are fundamental issues pertaining to all autoimmune disorders. Significant decrease in antibody titer were observed in another study on eliminating cow’s milk and related products from the diet of children with positive blocking FR autoantibody titers (14). This led to the hypothesis that the production of blocking FR autoantibodies is caused by exposure to the antigen (cow’s milk FR) due to a defect in the immunological barrier of the gastrointestinal tract.

Further investigation is required to understand the nature of the association between FR autoimmunity and subfertility and potential benefits of using immune suppressants, corticosteroids and high dose folic acid in this disorder.


Financial support: This study was supported by the grants: ALI 89-0388 and SAF 2005-05096 (Comision Interministerial de Ciencia y Tecnología), Spain; Fundació Caixa Sabadell 2006, Spain; HD051880 NIH, USA.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000;71(suppl):1295S–303S. [PubMed]
2. Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006;83:993–1016. [PubMed]
3. Friso S, Choi Sang-Woo. Gene-nutrient interactions and DNA methylation. J Nutr. 2002;132:2382S–2387S. [PubMed]
4. Hibbard ED, Smithells RW. Folic acid metabolism and embryopathy. Lancet. 1965;1:1254–6.
5. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944–50. [PMC free article] [PubMed]
6. Kirke PN, Molloy AM, Daly SE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. QJM. 1993;86:703–8. [PubMed]
7. O’Neill CO. Endogenous folic acid is essential for normal development of preimplantation embryos. Hum Reprod. 1998;13:1312–6. [PubMed]
8. Steegers-Theunissen RPM, Smith SC, Steegers EAP, Guilbert LJ, Baker PN. Folate affects apoptosis in human trophoblastic cells. Br J Obstet Gynaecol. 2000;107:1513–5. [PubMed]
9. George L, Mills JL, Johansson ALV, Nordmark A, Olander B, Granath F, et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288:1867–73. [PubMed]
10. Da Costa M, Sequeira JM, Rothenberg SP, Weedon J. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Research (Part A) 2003;67:837–47. [PubMed]
11. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004;350:134–42. [PubMed]
12. Bliek JB, Rothenberg SP, Steegers-Theunissen RPM. Maternal folate receptor autoantibodies and cleft lip and/or palate. Int J Gynaecol Obstet. 2006;93:142–3. [PubMed]
13. Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352:1985–91. [PubMed]
14. Rameakers VT, Sequeira JM, Blau N, Quadros EV. A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome. Dev Med Child Neurol. 2008;50:346–52. [PMC free article] [PubMed]
15. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoaimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38:276–81. [PubMed]
16. Ramaekers VT, Sequeira JM, Artuch R, Blau N, Temudo T, Ormazabal A, et al. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome. Neuropediatrics. 2007;38:179–83. [PubMed]
17. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796–9. [PubMed]
18. Blohm F, Fridén B, Milsom I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BJOG. 2008;115:176–82. [PubMed]
19. Nguyen RHN, Wilcox AJ. Terms in reproductive and perinatal epidemiology: I. Reproductive terms. J Epidemiol Community Health. 2005;59:916–9. [PMC free article] [PubMed]
20. Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr. 2002;76:614–9. [PubMed]
21. Murphy MM, Scott JM, Arija V, Molloy AM, Fernández-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predict fetal homocysteine and birth weight. Clin Chem. 2004;50:1406–12. [PubMed]
22. Murphy MM, Molloy AM, Ueland PM, Fernandez-Ballart JD, Schneede J, Arija V, et al. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr. 2007;137:1863–7. [PubMed]
23. Ethical committee of the World Medical Association. Draft code of ethics on human experimentation. BMJ. 1964;2:177–80. [PMC free article] [PubMed]
24. Linsten AME, Pasker-de Jong PCM, de Boer EJ, Burger CW, Jansen CAM, Braat DDM, et al. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod. 2005;20:1867–75. [PubMed]
25. Smick HKA, Amick TS, Evers JLH, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod. 1997;12:1582–8. [PubMed]
26. Elnakat H, Ratnam M. Role of folate receptor genes in reproduction and related cancers. Front Biosci. 2006;11:506–19. [PubMed]
27. Ebisch IMW, Thomas CMG, Peters WHM, Braat DDM, Steegers-Theunissen RPM. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13(2):163–74. [PubMed]
28. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28. [PMC free article] [PubMed]
29. Vanselow J, Pöhland R, Fürbas R. Promoter-2-derived Cyp19 expression in bovine granulosa cells coincides with gene-specific DNA hypo-methylation. Mol Cel Endocrinol. 2005;233:57–64. [PubMed]
30. Yu J, Yu L, Bugawan TL, Erlich HA, Barriga K, Hoffman M, et al. Transient antiislet autoantibodies: infrequent occurrence and lack of association with genetic risk factors. J Clin Endocrinol Metab. 2000;85:2421–8. [PubMed]
31. Cheng HM, Chamley L. Cryptic natural autoantibodies and co-potentiators. Autoimmun Rev. 2008;7:431–4. [PubMed]